4.3 Review

Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia

期刊

NEUROMOLECULAR MEDICINE
卷 23, 期 1, 页码 1-24

出版社

HUMANA PRESS INC
DOI: 10.1007/s12017-021-08644-4

关键词

Alzheimer’ s disease; APOE; Frontotemporal dementia; Granulin; Dementia with Lewy bodies; Parkinson’ s disease; Glucocerebrosidase; Lipid; Dementia

资金

  1. National Health and Medical Research Council of Australia [APP1100626, APP1163429]
  2. Research Training Program scholarships (Department of Education, Skills and Employment, Australia)

向作者/读者索取更多资源

Dementia poses an increasing burden to healthcare and social services as populations age worldwide. Genomic studies have identified lipid metabolism abnormalities as a common pathogenic mechanism in various forms of dementia, with mutations in genes such as APOE and GBA contributing to genetic risk factors.
Dementia poses an ever-growing burden to health care and social services as life expectancies have grown across the world and populations age. The most common forms of dementia are Alzheimer's disease (AD), vascular dementia, frontotemporal dementia (FTD), and Lewy body dementia, which includes Parkinson's disease (PD) dementia and dementia with Lewy bodies (DLB). Genomic studies over the past 3 decades have identified variants in genes regulating lipid transporters and endosomal processes as major risk determinants for AD, with the most significant being inheritance of the epsilon 4 allele of the APOE gene, encoding apolipoprotein E. A recent surge in research on lipid handling and metabolism in glia and neurons has established defective lipid clearance from endolysosomes as a central driver of AD pathogenesis. The most prevalent genetic risk factors for DLB are the APOE epsilon 4 allele, and heterozygous loss of function mutations in the GBA gene, encoding the lysosomal catabolic enzyme glucocerebrosidase; whilst heterozygous mutations in the GRN gene, required for lysosomal catabolism of sphingolipids, are responsible for a significant proportion of FTD cases. Homozygous mutations in the GBA or GRN genes produce the lysosomal storage diseases Gaucher disease and neuronal ceroid lipofuscinosis. Research from mouse and cell culture models, and neuropathological evidence from lysosomal storage diseases, has established that impaired cholesterol or sphingolipid catabolism is sufficient to produce the pathological hallmarks of dementia, indicating that defective lipid catabolism is a common mechanism in the etiology of dementia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据